What we do
CTA coordinates feasibility and clinical trial administration across a network of hospitals and research institutes, so sponsors deal with one team and sites can focus on patients.
Find the service that fits
For Sponsors & CROs
Run your study through one coordinated network, from first-in-human feasibility to close-out. One point of contact, specialist start-up staff and a network of experienced sites.
For Member Sites
Trial administration management from start-up to trial completion, as a full service or on a fee-for-service basis for specific projects.
Why run your oncology trial in Australia?
Australia combines a quality healthcare system with a strong network of universities, independent medical research institutes, biobanks, CROs and clinical trial networks.
Streamlined Regulation
Most clinical trials in Australia are conducted under the Clinical Trials Notification (CTN) scheme, which reduces cost, time and regulatory burden for sponsors, including for first-time-in-human and Phase I trials.
A Hub for Early Phase
Australia is recognised as a hub for early phase trials, and many international biotech and pharmaceutical companies continue to launch early phase studies here. Ranked #3 globally for Phase 1 trials (CTA Annual Report 2025).
Skilled Researchers
Sponsors have access to highly skilled researchers and key opinion leaders working within internationally recognised, world-class medical research infrastructure.
Financial Incentives
International sponsors can take advantage of Australia’s attractive R&D tax credit scheme to support local drug development programs.
Strong IP Protection
Australia provides a strong intellectual property protection environment for new drugs and molecules.
Where CTA Fits
CTA connects you to the network’s sites and manages the start-up work that gets a study moving.
Considering Australia for your next study?
Talk to the team about feasibility, early phase trials and how the network can support your program.
